Advanced in Sideroblastic Anemia

Dr. Boris Bagdasarian

Oncology | Hematology
1505 Wilson Terrace, Suite 200, 
Glendale, CA 
Accepting New Patients
Offers Telehealth
Advanced in Sideroblastic Anemia
1505 Wilson Terrace, Suite 200, 
Glendale, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Boris Bagdasarian is a Hematologist and an Oncologist in Glendale, California. Dr. Bagdasarian is rated as an Advanced provider by MediFind in the treatment of Sideroblastic Anemia. His top areas of expertise are Chronic Familial Neutropenia, Agranulocytosis, Langerhans Cell Histiocytosis, and Thrombocytopenia. Dr. Bagdasarian is currently accepting new patients.

His clinical research consists of participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Oncology
Hematology
Licenses
Internal Medicine in CA
Hospital Affiliations
Keck Hospital Of USC
USC Verdugo Hills Hospital
Glendale Adventist Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

1505 Wilson Terrace, Suite 200, Glendale, CA 91206

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Multicenter, Randomized, Open-label Phase 2 Study Evaluating the Safety and Efficacy of Three Different Regimens of Oral Panobinostat in Combination With Subcutaneous Bortezomib and Oral Dexamethasone in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma Who Have Been Previously Exposed to Immunomodulatory Agents
A Multicenter, Randomized, Open-label Phase 2 Study Evaluating the Safety and Efficacy of Three Different Regimens of Oral Panobinostat in Combination With Subcutaneous Bortezomib and Oral Dexamethasone in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma Who Have Been Previously Exposed to Immunomodulatory Agents
Enrollment Status: Completed
Publish Date: July 12, 2024
Intervention Type: Drug
Study Drugs: Panobinostat Capsules, Bortezomib Injection, Dexamethasone Tablets
Study Phase: Phase 2
A Phase II, Multicenter Study of Oral MET Inhibitor INC280 in Adult Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1)
A Phase II, Multicenter Study of Oral MET Inhibitor INC280 in Adult Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1)
Enrollment Status: Completed
Publish Date: March 20, 2024
Intervention Type: Drug
Study Drug: INC280
Study Phase: Phase 2
A Phase Ib/II, Open-label, Multicenter Trial With Oral cMET Inhibitor INC280 Alone and in Combination With Erlotinib Versus Platinum With Pemetrexed in Adult Patients With EGFR Mutated, cMET-amplified, Locally Advanced/Metastatic Non-small Cell Lung Cancer (NSCLC) With Acquired Resistance to Prior EGFR Tyrosine Kinase Inhibitor (EGFR TKI)
A Phase Ib/II, Open-label, Multicenter Trial With Oral cMET Inhibitor INC280 Alone and in Combination With Erlotinib Versus Platinum With Pemetrexed in Adult Patients With EGFR Mutated, cMET-amplified, Locally Advanced/Metastatic Non-small Cell Lung Cancer (NSCLC) With Acquired Resistance to Prior EGFR Tyrosine Kinase Inhibitor (EGFR TKI)
Enrollment Status: Terminated
Publish Date: February 24, 2020
Intervention Type: Drug
Study Phase: Phase 1
View 2 Less Clinical Trials
Similar Doctors
Ryotaro Nakamura
Advanced in Sideroblastic Anemia
Dr. Ryotaro Nakamura
Oncology
Advanced in Sideroblastic Anemia
Dr. Ryotaro Nakamura
Oncology

Ryotaro Nakamura, M.D.

1500 Duarte Rd, 
Duarte, CA 
 (14.9 miles away)
800-826-4673
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ryotaro Nakamura is an Oncologist in Duarte, California. Dr. Nakamura is rated as an Elite provider by MediFind in the treatment of Sideroblastic Anemia. His top areas of expertise are Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Marrow Aspiration.

Advanced in Sideroblastic Anemia
Dr. Dilruba Haque
Hematology | Oncology
Advanced in Sideroblastic Anemia
Dr. Dilruba Haque
Hematology | Oncology

The Oncology Institute

11525 Brookshire Ave Ste 202, 
Downey, CA 
 (15.6 miles away)
562-869-1201
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Dilruba Haque is a Hematologist and an Oncologist in Downey, California. Dr. Haque is rated as a Distinguished provider by MediFind in the treatment of Sideroblastic Anemia. Her top areas of expertise are Rhabdomyosarcoma Embryonal, Undifferentiated Pleomorphic Sarcoma, Adult Soft Tissue Sarcoma, and Non-Hodgkin Lymphoma.

Advanced in Sideroblastic Anemia
Dr. Greg Angstreich
Hematology
Advanced in Sideroblastic Anemia
Dr. Greg Angstreich
Hematology

Orange Coast Cardiology Medical Corp.

520 Superior Ave Ste 300, 
Newport Beach, CA 
 (40.2 miles away)
949-646-6441
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Greg Angstreich is a Hematologist in Newport Beach, California. Dr. Angstreich is rated as a Distinguished provider by MediFind in the treatment of Sideroblastic Anemia. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Richter Syndrome, B-Cell Lymphoma, and Chronic B-Cell Leukemia (CBCL).

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bagdasarian's expertise for a condition
ConditionClose
    View All 32 Distinguished Conditions
    View All 103 Advanced Conditions
    View All 105 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile